Rea GME, Lantigua CA, Méndez RLA

Language: Spanish
References: 25
Page: 32-39
PDF size: 690.35 Kb.

ABSTRACT

The clinical evolution of a patient with ring chromosome 13 through the karyotype-phenotype relationship. The specific dysmorphologic changes and the hematological and immunochemical parameters are described. Finally, the clinical manifestations are related to the cytogenetic findings.

REFERENCES

1. Brown Stephen, Gersen Steven, Anyane-Yeboa Kwame and Warburton Dorothy. Preliminary Definition of a “Critical Region” of Chromosome 13 in q32: Report of 14 Cases With 13q Deletions and Review of the Literature American Journal of Medical Genetics; 1993: 4552-59.

2. Gardner RJMcK, Sutherland GR. Chromosome abnormalities detected at prenatal diagnosis. In: Gardner RJMcK, Sutherland GR editors. Chromosome abnormalities and genetic counseling. 3rd ed, New York: Oxford University Press Inc; 2004: 392-432.

3. Cowell J K, Mitchell C D. A somatic cell hybrid mapping panel for regional assignment of human chromosome 13 DNA sequences. Cytogenet Cell Genet 1989, 52:1-6.

4. Dunham A, Matthews LH, Burton J, Ashurst JL, Howe KL, Ashcroft KJ. et al. The DNA sequence and analysis of human chromosome 13. Nature 2004; 428 (6982): pp. 522-8

5. Brown S, Russo J, Chitayat D. The 13q-syndrome: the molecular definition of a critical deletion region in band 13q32. Am J Med Genet 1995,57:859-866.

6. Kasyan AG, Benirschke K. Genetic haploinsufficiency as a phenotypic determinant of a deletion 13q syndrome. Pediatr Dev Pathol 2005, 8:658–665.

7. Kirchhoff M, Pedersen S, Kjeldsen E, Rose H, Dunø M, Kølvraa S, Lundsteen C, et al. Prospective study comparing HR-CGH and subtelomeric FISH for investigation of individuals with mental retardation and dysmorphic features and an update of a study using only HR-CGH. Am J Med Genet A 2004; 127: 111-7.

8. Kirchhoff M, Bisgaard A, Stoeva R, Dimitrov B, Gillesen-Kaesbach G, Fryns JP, et al. Phenotype and 244k array-CGH characterization of chromosome 13q deletions: An update of the phenotypic map of 13q21.1-qter. Am J Med Genet Part A 2009.149A: 894–905.

9. Gentile M, Buonadona A, Cariola F, Fiorente P, Valenzano M, Guanti G. Molecular and cytogeneticchararcterisation of an usual case of partial trisomy/partial monosomy 13 mosaicism: 46,XX, r(13) (p11q14)/46,XX, der (13) t (13;13) (q10,q14). J Med Genet. 1999, 36: 77-82

10. Bedoyan J K, Flore L A, Alkatib A, Ebrahim S A, Bawle E V. Transmission of ring chromosome 13 from a mother to daughter with both having a 46,XX, r(13)(p13q34) karyotype. Am J Med Genet A. 2004, 129A (3):316-20.

11. Walczak-Sztulpa J, Wisniewska M, Latos-Bielenska A. Chromosome deletions in 13q33-34: report of four patients and review of the literature. Am J Med Genet Part A 2008, 146A:337334.

12. Jauffret E. Spina bifida. Encycl. Méd. Chir. (Elsevier, Paris France), Kinésithérapie-Médecine physique.Réadaptation 1997, 26-472-B-10, 1-18.

13. Cordobés F, Budke M. El disrafismo espinal oculto. Rev, Pediatría Integral 2010; XIV (10): 811-821.

14. Haider AS, Lowe MA, Suarez M, Zaba LC, Cardinale I, Khatcherian A, et al. Identification of cellular pathways of ‘‘type 1’’, Th17 T cells, and TNF- and inducible nitric oxide synthaseproducing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol 2008 b, 180: 1913-20.

15. Di Cesare A, Di Meglio P, Nestle F. The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis. Journal of Investigative Dermatology (2009), Volume 129: 1339-1350.

16. Sankar, V.H., Shubha R. Phadke. Case report of Ring Chromosome 13 in an Infant with Ambiguous Genitalia. Indian Pediatrics. 2006 Volume 43 March 17, 258-260.

17. Brandt CA, Hertz JM, Peterson MB, Vogel F, Noer H, Mikkelsen M. Ring chromosome 13: lack of distinct syndromes base don different breakpoints on 13q. J Med Genet 1992, 29: 704708.

18. Kosztolányi G. The genetics and clinical caracteristics of constitutional ring chromosomes. J. Assoc. Genet. Technol. 2009 35: 44-48.

19. Sodré. C.P, Guilherme R.S, Meloni V.F.A. Brunoni D, Juliano Y, Andrade JAD, Belangero SIN, et al. Ring chromosome instability evaluation in six patients with autosomal rings. Genet. Mol. Res. 2010 9 (1): 134-143.

20. Conlin Laura K, Thiel Brian D, Bonnemann Carsten G, Medne Livija, Ernst Linda M, Elaine H. Zackai, et al. Mechanisms of mosaicism, chimerism, and uniparental disomy identified by SNP array analysis. Hum Mol Genet 2010; 19: 1263-1275.

21. Basel-Vanagaite L. Clinical approaches to genetic mental retardation, Isr Med Assoc J 2008, 10:821-826.

22. Bishop D V. Genes, cognition, and communication: insights from neurodevelopmental disorders, Ann N Y Acad Sci 2009, 1156:1-18.

23. Ballarati L, Deletion 13q and central nervous system anomalies; Further insights from karyotype-phenothype analyses of 14 patients. J Med Genet 2007, 44: 60.

24. Amor D J, Voullaire L, Bentley K, Savarirayan R, Choo KH. Mosaic monosomy of a neocentric ring chromosome maps brachyphalangy and growth hormone deficiency to 13q31.1–13q32.3. Am J Med Genet Part A 2005, 133A:151–157.

25. Christofolini DM, Yoshimoto M, Squire JA, Brunoni DC, Melaragno MI, Carvalheira G. Hydrocephaly, penoscrotal transposition, and digital anomalies associated with de novo pseudodicentric rearranged chromosome 13 characterized by classical cytogenetic methods and mBAND analysis. Am J Med Genet Part A 2006, 140A:1321–1325.